This week’s plant medicine newsletter covers the retail shift away from CBD toward intoxicating hemp derivatives, the environmental toll of outdated cannabis packaging laws, the harrowing consequences of cannabis prohibition in Singapore, and new research on CBD as a psoriasis therapy and its prevalence of use among U.S. adults.
Noteworthy Read
Convenience Stores & Smoke Shops Leaving CBD Behind (Green Market Report)
Green Market Report highlights a recent trend in which convenience stores and smoke shops are shifting away from CBD products, opting instead for intoxicating hemp derivatives like Delta-8, Delta-9, and Delta-10 THC, as consumer interest in non-intoxicating CBD wanes.
More Noteworthy Reading
Outdated Marijuana Packaging Rules Make It Impossible for Cannabis Industry to Be Environmentally Sustainable (Marijuana Moment)
A recent study highlights that current marijuana packaging regulations, particularly in California, are contributing to significant environmental waste, making it challenging for the cannabis industry to adopt sustainable practices.
Inside the Prison That Executes People for Supplying Cannabis (CNN)
Singapore’s Changi Prison enforces strict penalties, including the death sentence, for drug-related offenses such as cannabis trafficking, reflecting the nation’s unwavering stance against narcotics.
Research Round-Up
CBD for Psoriasis (American Journal of Clinical & Medical Research)
A recent study explores the potential of cannabidiol (CBD) oil as an adjunct therapy for psoriasis, focusing on its anti-inflammatory and immunomodulatory properties, while also addressing the regulatory challenges associated with its use.
Prevalence of CBD Use and Correlates in US Adults (Drug and Alcohol Dependence Reports)
A study using the 2022 U.S. National Survey on Drug Use and Health found that 20.6% of adults used CBD in the past year, with 63% also using cannabis. CBD-only users were more likely to be women, older, and of higher socioeconomic status, while co-users faced greater health risks, highlighting the need for public health warnings and further research on the effects of CBD and cannabis co-use.
A heartfelt thank you to all of the CBD brands whose generous support fuels Project CBD’s commitment to bringing you the latest and most important plant medicine research and journalism each week. Your partnership truly makes a difference.
